Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F12%3A13558" target="_blank" >RIV/00216208:11110/12:13558 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11120/12:43906566
Result on the web
<a href="http://dx.doi.org/10.1186/1477-7819-10-220" target="_blank" >http://dx.doi.org/10.1186/1477-7819-10-220</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields
Original language description
Glioblastoma multiforme (GBM) is the most common and malignant primary intracranial tumor, and has a median survival of only 10 to 14 months with only 3 to 5% of patients surviving more than three years. Recurrence (RGBM) is nearly universal, and furtherdecreases the median survival to only five to seven months with optimal therapy. Tumor-treating fields (TTField) therapy is a novel treatment technique that has recently received CE and FDA approval for the treatment of RGBM, and is based on the principle that low intensity, intermediate frequency electric fields (100 to 300 kHz) may induce apoptosis in specific cell types. Our center was the first to apply TTField treatment to histologically proven GBM in a small pilot study of 20 individuals in 2004and 2005, and four of those original 20 patients are still alive today. We report two cases of GBM and two cases of RGBM treated by TTField therapy, all in good health and no longer receiving any treatment more than seven years after init
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FH - Neurology, neuro-surgery, nuero-sciences
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
World Journal of Surgical Oncology
ISSN
1477-7819
e-ISSN
—
Volume of the periodical
10
Issue of the periodical within the volume
Article Number: 220
Country of publishing house
GB - UNITED KINGDOM
Number of pages
6
Pages from-to
1-6
UT code for WoS article
000311962700001
EID of the result in the Scopus database
—